Investing Profile

Vincent Miles

InvestorVC
Partner at Abingworth
Photo of Vincent Miles, Partner at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
UCL Network
104 CONNECTIONS
Pfizer Network
53 CONNECTIONS
cb
Abingworth Partner
$15.0M - $30.0M
$22.5M
7
$465M
CompanyStageDateRound SizeTotal Raised
Chiasma
Series EFeb 2015$70M
Series DJul 2012$39M
$160M
Co-investors: Todd Foley (MPM Capital), Scott Minick (ARCH Venture Partners), Bard Geesaman (MPM Capital), Ansbert Gadicke (MPM Capital)
PrimeraDx (Primera Biosystems)
Series COct 2009$20M
Series BJan 2008$21M
$41M
Co-investors: Nina Kjellson (Canaan Partners)
Hydra Biosciences
Series DJan 2009$22M
Series CMar 2008$34M
Series BJan 2004$19M
$84M
Co-investors: Jonathan MacQuitty (Lightspeed Venture Partners), Alan Crane (Polaris Partners), Jean George (Advanced Technology Ventures), Christoph Westphal (Self-employed)
Higher Scientific Officer HotmailPresent
R&D and Business Development HotmailPresent
VP, R&D (Molecular Biology Division) PfizerPresent
VP, International Marketing (Molecular Biology Division) PfizerPresent
VP, R&D and Business Development HotmailPresent
Director, Office of Technology Transfer Dana-Farber Cancer InstitutePresent
VP, Business Development, Technology Management Takeda OncologyPresent
Senior VP, Business Development Alnylam PharmaceuticalsPresent
Executive Director AbingworthPresent
Partner AbingworthPresent
UCL B.Sc. (biochemistry) Ph.D. (biochemical embryology/molecular biology)